1. Home
  2. IPHA vs CZWI Comparison

IPHA vs CZWI Comparison

Compare IPHA & CZWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPHA
  • CZWI
  • Stock Information
  • Founded
  • IPHA 1999
  • CZWI 1938
  • Country
  • IPHA France
  • CZWI United States
  • Employees
  • IPHA N/A
  • CZWI N/A
  • Industry
  • IPHA Biotechnology: Pharmaceutical Preparations
  • CZWI Savings Institutions
  • Sector
  • IPHA Health Care
  • CZWI Finance
  • Exchange
  • IPHA Nasdaq
  • CZWI Nasdaq
  • Market Cap
  • IPHA 160.1M
  • CZWI 132.7M
  • IPO Year
  • IPHA 2019
  • CZWI N/A
  • Fundamental
  • Price
  • IPHA $2.38
  • CZWI $14.80
  • Analyst Decision
  • IPHA Strong Buy
  • CZWI
  • Analyst Count
  • IPHA 1
  • CZWI 0
  • Target Price
  • IPHA $11.00
  • CZWI N/A
  • AVG Volume (30 Days)
  • IPHA 31.8K
  • CZWI 18.3K
  • Earning Date
  • IPHA 03-27-2025
  • CZWI 04-28-2025
  • Dividend Yield
  • IPHA N/A
  • CZWI 2.47%
  • EPS Growth
  • IPHA N/A
  • CZWI N/A
  • EPS
  • IPHA N/A
  • CZWI 1.27
  • Revenue
  • IPHA $20,831,349.00
  • CZWI $58,040,000.00
  • Revenue This Year
  • IPHA $209.83
  • CZWI N/A
  • Revenue Next Year
  • IPHA $83.96
  • CZWI $12.31
  • P/E Ratio
  • IPHA N/A
  • CZWI $11.48
  • Revenue Growth
  • IPHA N/A
  • CZWI N/A
  • 52 Week Low
  • IPHA $1.29
  • CZWI $10.64
  • 52 Week High
  • IPHA $3.51
  • CZWI $17.04
  • Technical
  • Relative Strength Index (RSI)
  • IPHA 71.42
  • CZWI 56.31
  • Support Level
  • IPHA $2.13
  • CZWI $14.47
  • Resistance Level
  • IPHA $2.34
  • CZWI $15.20
  • Average True Range (ATR)
  • IPHA 0.14
  • CZWI 0.40
  • MACD
  • IPHA 0.04
  • CZWI 0.06
  • Stochastic Oscillator
  • IPHA 90.07
  • CZWI 65.48

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

About CZWI Citizens Community Bancorp Inc.

Citizens Community Bancorp Inc is a bank holding company that offers traditional community banking services to businesses, Agricultural operators, and consumers, including one-to-four-family residential mortgages. it also offers a variety of loan products including commercial real estate loans, commercial and industrial (C&I) loans, agricultural real estate loans, agricultural operating loans, residential mortgages, home equity lines-of-credit, and consumer loans and offers deposit products through its branches, including demand deposits, various savings and money-market accounts and certificates of deposit. The company's sources of funds are deposits; amortization, prepayments, and maturities of outstanding loans; other short- term investments; and funds provided from operations.

Share on Social Networks: